Immunome Inc reports results for the quarter ended in December - Earnings Summary

Immunome

28/03/2024 21:13

* Immunome Inc  IMNM.OQ  reported a quarterly adjusted loss
of
$4.22​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -64
cents.  The mean expectation of three analysts for the quarter
was for a loss of 28 cents per share. Wall Street expected
results to range from -37 cents to -23 cents per share.
    * Revenue was $3.83 million​; analysts expected $2.07
million. 
    * Immunome Inc's reported EPS for the quarter was a loss of
$4.22​.
    * The company reported a quarterly loss of $92.63 million.
    * Immunome Inc shares had risen by 138.5% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 18.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Immunome
Inc is
$32.50 

This summary was machine generated from LSEG data March 28 at
09:13 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.28          -4.22          Missed
 Jun. 30 2023      -0.16          -0.46          Missed
 Mar. 31 2023      0.59           -0.35          Missed